Rhopressa (netarsudil)

Approved for 1 INDICATIONS AND USAGE RHOPRESSA is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. RHOPRESSA ® is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 ). 12.1 Mechanism of Action Netarsudil is a rho kinase…

Loading full data from Know Your Drugs Institute…